Sanofi taps NBA players to assist in teen vaccine awareness

Share this article:
Sanofi taps NBA players to assist in teen vaccine awareness
Sanofi taps NBA players to assist in teen vaccine awareness

Sanofi Pasteur, the vaccines division of Sanofi-Aventis, tapped Denver Nuggets all-star Chauncey Billups as its 2011 spokesperson for Vaccines for Teens, an ongoing educational and awareness campaign. Other players will join the effort in local markets this year, in concert with the NBA, WNBA and the Society for Adolescent Health and Medicine (SAHM).

The campaign first launched in February 2009, with Grant Hill of the Phoenix Suns as spokesperson, and new PSAs starring Billups will air nationally on NBA media and during televised NBA games on network and cable channels. “As a father, nothing is more important to me than my children's health,” said Billups in a release dated February 3. “I encourage parents to speak to their child's healthcare provider and get informed about how they can help protect their preteens and teens by getting them vaccinated.”

In Miami this morning, NBA legend Bob Lanier and Miami Heat forward Juwan Howard joined Lawrence Friedman of the SAHM, and Tricia Reilly and Natasha Davis, sisters of Rhett Davis, who died of meningococcal disease, to speak with middle schoolers about the importance of getting vaccinated. Events are scheduled for Los Angeles next week, and Dallas in March, according to an NBA spokesperson, but NBA players for those appearances are yet to be determined. The WNBA will be involved in three events after its season kicks off on June 3, the spokesperson said.

The campaign's web presence – – offers information and statistics related to influenza, HPV, meningitis and pertussis, as well as links to national health organizations. “The best offense is a good defense,” Billups says in the PSA, which is available for viewing on the site. New York-based PR shop Cooney Waters is working on the campaign, according to a Sanofi spokesperson.

Sanofi Pasteur was the second largest vaccines company in 2009, with global sales at $5.7 billion. In 2010, the company had sales of $4.3 billion for the first three quarters, according to Datamonitor. Menactra (for the prevention of meningococcal disease), Daptacel (a diphtheria and tetanus toxoids and acellular pertussis, or DTaP vaccine), Adacel (a Tdap vaccine), Pentacel (a DTap-IPV/Hib combo vaccine) and Fluzone (for influenza) have been the strongest growth drivers for the company, according to Datamonitor. The Vaccines for Teens campaign is unbranded.

Share this article:
You must be a registered member of MMM to post a comment.

Next Article in Channel

Email Newsletters

MM&M Future Leaders

Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 


Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...